Store at room temperature away from moisture and heat.
-Initial dose: 10 mg orally once a day, as needed, approximately 60 minutes before sexual activity.
Grapefruit and Seville oranges may interact with vardenafil and cause side effects. Avoid consuming grapefruit products and orange marmalades. Drinking alcohol can increase certain side effects of Levitra. Do not use any other medicine to treat impotence unless your doctor tells you to. Get emergency medical help if you have signs of an allergic reaction to Levitra: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using Levitra and get emergency medical help if you have: heart attack symptoms - chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating; heart attack symptoms - chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating; vision changes or sudden vision loss; or vision changes or sudden vision loss; or erection is painful or lasts longer than 4 hours (prolonged erection can damage the penis). erection is painful or lasts longer than 4 hours (prolonged erection can damage the penis). Stop using Levitra and call your doctor at once if you have: ringing in your ears, or sudden hearing loss; ringing in your ears, or sudden hearing loss; swelling in your hands, ankles, or feet; swelling in your hands, ankles, or feet; a light-headed feeling, like you might pass out; or a light-headed feeling, like you might pass out; or flushing (sudden warmth, redness, or tingly feeling); flushing (sudden warmth, redness, or tingly feeling); This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Increase to 20 mg or decrease to 5 mg based on efficacy and tolerability. -Maximum dose: 20 mg once a day Patients on stable alpha blocker therapy: -Initial dose: 5 mg orally once a day Comments: -Sexual stimulation is required for a response to treatment. -A time interval between dosing should be considered when administering this drug concomitantly with alpha-blockers.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Levitra Generic | 40mg | 180 + 10 Pills | 405.06€ 385.77€ | |
| Levitra Generic | 60mg | 60 + 4 Pills | 198.85€ 189.38€ | |
| Levitra Generic | 20mg | 60 + 6 Pills | 131.11€ 124.87€ | |
| Levitra Soft Tabs | 20mg | 20 Pills | 74.68€ 71.12€ | |
| Levitra Generic | 60mg | 270 + 10 Pills | 714.53€ 680.50€ | |
| Levitra Generic | 10mg | 30 + 4 Pills | 62.39€ 59.42€ | |
| Levitra Original | 20mg | 12 Pills | 81.99€ 78.09€ | |
| Levitra Generic | 40mg | 120 + 8 Pills | 302.37€ 287.97€ | |
| Levitra Soft Tabs | 20mg | 270 + 10 Pills | 521.78€ 496.93€ | |
| Levitra Original | 20mg | 120 + 8 Pills | 528.19€ 503.04€ | |
| Levitra Generic | 40mg | 90 + 6 Pills | 234.73€ 223.55€ | |
| Levitra Generic | 20mg | 120 + 10 Pills | 224.15€ 213.48€ | |
| Levitra Generic | 20mg | 360 + 10 Pills | 458.44€ 436.61€ | |
| Levitra Original | 20mg | 4 Pills | 45.87€ 43.69€ | |
| Levitra Generic | 10mg | 360 + 10 Pills | 407.94€ 388.51€ |
65 years or older: -Initial dose: 5 mg orally once a day, as needed, approximately 60 minutes before sexual activity Comments: Sexual stimulation is required for a response to treatment.
Since Levitra is used as needed, you are not likely to be on a dosing schedule.
Store at room temperature away from moisture and heat. -Initial dose: 10 mg orally once a day, as needed, approximately 60 minutes before sexual activity. Increase to 20 mg or decrease to 5 mg based on efficacy and tolerability. -Maximum dose: 20 mg once a day Patients on stable alpha blocker therapy: -Initial dose: 5 mg orally once a day Comments: -Sexual stimulation is required for a response to treatment. -A time interval between dosing should be considered when administering this drug concomitantly with alpha-blockers.
65 years or older: -Initial dose: 5 mg orally once a day, as needed, approximately 60 minutes before sexual activity Comments: Sexual stimulation is required for a response to treatment. Since Levitra is used as needed, you are not likely to be on a dosing schedule. Do not take Levitra more than once a day. Allow 24 hours to pass between doses. Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. Do not take Levitra more than once a day. Allow 24 hours to pass between doses. Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. Grapefruit and Seville oranges may interact with vardenafil and cause side effects.
The )]TJ 0.0008 Tc -0.0018 Tw -18.37 -1.15 Td [(f)3.8 (o)0.8 (llowing se)4.6 (ction identif)3.8 (i)-1.4 (es add)5.8 (ition)5.8 (a)4.6 (l, less f)3.8 (r)-1.2 (equ)5.8 (e)]TJ 0.001 Tc 19.99 0 Td [(nt events \(<)5 (2%\) repo)6 (rte)4.8 (d)1 ( during th)6 (e clin)6 (ical )]TJ 0.0006 Tc -0.002 Tw -19.99 -1.15 Td [(developm)8.4 (ent of LEVITRA. Excluded from)8.4 ( this list ar)]TJ -0.0027 Tw 21.44 0 Td [(e those events that are infrequ)5.6 (e)4.4 (nt and m)8.4 (i)-1.6 (nor, )]TJ 0.0003 Tc -0.0009 Tw -21.44 -1.145 Td [(those events that m)8.1 (a)-0.9 (y be commonly observed in the )]TJ 0.0001 Tc -0.0013 Tw (absence of drug therapy, a)Tj 0.0003 Tc -0.0015 Tw 31.49 0 Td (nd those events that are )Tj -0.0001 Tc 0.0001 Tw -31.49 -1.155 Td (not reasonably associated with the drug. )Tj 0 Tc 0.0037 Tw 1.5 -1.315 Td (BODY AS A WHOLE: anaphylactic)Tj 0.0008 Tc -0.0015 Tw 14.775 0 Td [( reaction \(in)5.8 (cluding lary)5.8 (ngeal edem)8.6 (a\), asthen)5.8 (ia, f)8.8 (ace edem)8.6 (a, )]TJ 0.0009 Tc 0 Tw -14.775 -2.3 Td (pain )Tj 0.0004 Tc -0.0004 Tw 0 -2.805 TD [(AUDITOR)-2.6 (Y)2.6 (: tinnitus )]TJ -0.0003 Tc 0.0003 Tw 0 -1.31 TD [(CARDIOVASCULAR:)-7.5 ( angina pectoris, ches)]TJ 0.0003 Tc -0.0003 Tw 18.11 0 Td [(t pain, hypertension, hypotension, m)8.1 (yocardial )]TJ 0.0005 Tc -0.0005 Tw -18.11 -1.155 Td [(ischem)8.3 (ia, myocardial inf)8.5 (a)-0.7 (rction, palpitation, )]TJ -0.0001 Tc 0.0001 Tw 17.97 0 Td (postural hypotension, s)Tj 0 Tc 0 Tw 9.245 0 Td (yncope, tachycardia )Tj 0.0002 Tc -0.0002 Tw -27.215 -1.31 Td [(DIGESTIVE: abdom)8 (inal pain, abnorm)8 (al liver f)]TJ -0.0027 Tw 18.88 0 Td [(unction tests, diarrhea, dry )-7.5 (m)8 (outh, dysphagia, )]TJ 0.0005 Tc -0.003 Tw -18.88 -1.155 Td [(esophagitis, gastritis, gas)4.7 (t)-1.7 (roesophag)5.5 (e)]TJ 0.0006 Tc -0.0006 Tw 14.83 0 Td [(al reflux, G)7.8 (G)2.8 (TP increas)4.8 (ed, vom)8.4 (iting )]TJ 0.0004 Tc -0.0004 Tw -14.83 -1.32 Td (MUSCULOSKELETAL: arthra)Tj 0.0005 Tc -0.0025 Tw 12.805 0 Td (lgia, back pain, myalgia, neck pain )Tj 0.0001 Tc -0.0017 Tw -12.805 -1.315 Td [(NERVOUS:)-7.1 ( hypertonia, hypesthesia, insom)7.9 (nia)]TJ 0.0002 Tc 18.855 0 Td [(, paresthesia, som)8 (nolence, vertigo )]TJ 0.0004 Tc -0.0004 Tw -18.855 -1.315 Td (RESPIRATORY: dyspnea, ep)Tj -0.0003 Tc 0.0003 Tw 12.09 0 Td (istaxis, pharyngitis )Tj 0 Tc 0.0016 Tw -12.09 -1.32 Td (SKIN AND APPENDAGES: photosensitivity)Tj 0.0002 Tc -0.0014 Tw 18.42 0 Td ( reaction, pruritus, rash, sweating )Tj ET q 1 0 0 1 -8.195038 -34.037292 cm /CS0 CS 0.004 0.004 0.004 SCN 0.75 w 1 j 1 J q 1 0 0 1 61.2 652.08 cm 0 0 m 432 0 l 0.48 -22.68 m 432.48 -22.68 l 0.48 -60.3 m 432.48 -60.3 l 0 -203.7 m 432 -203.7 l S Q Q /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 201 0 obj <>>>/Resources 234 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 202 0 obj <>>>/Resources 236 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 236 0 obj <> endobj 237 0 obj <> endobj 235 0 obj <>stream �5H�8CTzd#E���[��w���ᮆ�)ȼ�7�)��ࢠ1�97���8�������{�s ��~�N�4T$�C#A�}�A�_��r�y���XXm�d�=��jc����}�jˇX���(��? Proportion of vardenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm concentrationdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm countdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Proportion of sildenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo and vardenafil after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Washington, DC - The FDA gave approval yesterday to vardenafil (Levitra®, Bayer and Glaxo Smith Kline), an oral erectile-dysfunction drug that works through the same mechanism as sildenafil (Viagra®, Pfizer).
Like sildenafil, vardenafil can seriously affect blood pressure and should not be taken by those on alpha blockers or nitrates. The recommended dose is 10 mg taken one hour before sexual activity, with 20-, 5.0-, and 2.5-mg doses available. Vardenafil is a phosphodiesterase inhibitor and, like sildenafil, is strongly contraindicated if patients are taking nitrates (nitroglycerin tablets or patches) or alpha blockers, due to the possibility of a steep drop in blood pressure. Avoid consuming grapefruit products and orange marmalades. Drinking alcohol can increase certain side effects of Levitra. Do not use any other medicine to treat impotence unless your doctor tells you to. Get emergency medical help if you have signs of an allergic reaction to Levitra: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Do not use Levitra with similar medications levitra price costco such as avanafil (Stendra), sildenafil (Viagra), or tadalafil (Cialis). Tell your doctor about all other medications you use for erectile dysfunction. This list is not complete and many Other drugs may interact with vardenafil. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Levitra only for the for the indication prescribed. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Efficacy of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA treatment improved the patient's erectiondate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA improved the patient's erection after Minimum and Maximum Intervals between LEVITRA intake and the start of intercoursedate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Reporting a second successful intercourse within 24 hours of dosingdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Patients prefer LEVITRA over last Erectile Dysfunction treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Tolerability of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionYesSafety Issue: )]TJ /C2_0 1 Tf 0 Tc 0 Tw 7.98 0 0 7.98 49.405 366.8227 Tm <004A>Tj /TT1 1 Tf 12 0 0 12 52.705 361.3027 Tm ( )Tj /TT0 1 Tf 0.0001 Tc -0.0001 Tw 0.28 0 Td ( Flexible dose studies started all )Tj 0 Tc 0 Tw 13.055 0 Td [(patients at LEVITRA 10 m)7.8 (g)-5 ( and allo)]TJ -0.0002 Tc -0.0005 Tw 14.83 0 Td (wed decrease in dose to 5 mg or )Tj 0.0001 Tc -0.0001 Tw -27.66 -1.145 Td (increase in dose to 20 mg based on side effects and efficacy. )Tj 0 Tc -0.0006 Tw -0.78 -1.655 Td (Back pain was reported in 2.0% of patients treated)Tj 0 Tw ( with LEVITRA and 1.7% of patients on placebo. )Tj 0.0001 Tc -0.0026 Tw 0 -1.315 TD (Placebo-controlled trials suggested )Tj 0.0002 Tc -0.001 Tw 14.25 0 Td (a dose effect in the incidence of)Tj 0.0004 Tc -0.0016 Tw 12.71 0 Td [( som)8.2 (e)-0.8 ( adverse events \(headache, )]TJ -0.0003 Tw -26.96 -1.15 Td (flushing, dyspepsia, nausea, rhinitis\) over the )Tj 0.0001 Tc 0.0004 Tw 18.37 0 Td [(5 mg, 10 m)7.9 (g, and 20 m)7.9 (g doses of LEVITRA. Stop using Levitra and get emergency medical help if you have: heart attack symptoms - chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating; heart attack symptoms - chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating; vision changes or sudden vision loss; or vision changes or sudden vision loss; or erection is painful or lasts longer than 4 hours (prolonged erection can damage the penis). erection is painful or lasts longer than 4 hours (prolonged erection can damage the penis). Stop using Levitra and call your doctor at once if you have: ringing in your ears, or sudden hearing loss; ringing in your ears, or sudden hearing loss; swelling in your hands, ankles, or feet; swelling in your hands, ankles, or feet; a light-headed feeling, like you might pass out; or a light-headed feeling, like you might pass out; or flushing (sudden warmth, redness, or tingly feeling); flushing (sudden warmth, redness, or tingly feeling); This is not a complete list of side effects and others may occur.
| Advice | Explanation |
|---|---|
| Avoid alcohol | Can decrease effectiveness or increase side effects |
| Do not take with fatty meals | May delay absorption |
| Report adverse effects | Seek medical attention for prolonged erection or vision changes |
| Follow prescribed dose | Do not alter dose without consulting healthcare professional |
Call your doctor for medical advice about side effects.
| Condition | Description | Recommended use |
|---|---|---|
| Erectile Dysfunction | Difficulty in achieving or maintaining an erection | As prescribed by a doctor |
| Pulmonary Arterial Hypertension | Off-label use in some cases | Not approved without supervision |
| Menopause-related Sexual Dysfunction | Experimental treatment | Not approved officially |
You may report side effects to FDA at 1-800-FDA-1088. Do not use Levitra with similar medications levitra price costco such as avanafil (Stendra), sildenafil (Viagra), or tadalafil (Cialis). Tell your doctor about all other medications you use for erectile dysfunction. This list is not complete and many Other drugs may interact with vardenafil. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Levitra only for the for the indication prescribed. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Efficacy of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA treatment improved the patient's erectiondate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA improved the patient's erection after Minimum and Maximum Intervals between LEVITRA intake and the start of intercoursedate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Reporting a second successful intercourse within 24 hours of dosingdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Patients prefer LEVITRA over last Erectile Dysfunction treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Tolerability of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionYesSafety Issue: )]TJ /C2_0 1 Tf 0 Tc 0 Tw 7.98 0 0 7.98 49.405 366.8227 Tm <004A>Tj /TT1 1 Tf 12 0 0 12 52.705 361.3027 Tm ( )Tj /TT0 1 Tf 0.0001 Tc -0.0001 Tw 0.28 0 Td ( Flexible dose studies started all )Tj 0 Tc 0 Tw 13.055 0 Td [(patients at LEVITRA 10 m)7.8 (g)-5 ( and allo)]TJ -0.0002 Tc -0.0005 Tw 14.83 0 Td (wed decrease in dose to 5 mg or )Tj 0.0001 Tc -0.0001 Tw -27.66 -1.145 Td (increase in dose to 20 mg based on side effects and efficacy. )Tj 0 Tc -0.0006 Tw -0.78 -1.655 Td (Back pain was reported in 2.0% of patients treated)Tj 0 Tw ( with LEVITRA and 1.7% of patients on placebo. )Tj 0.0001 Tc -0.0026 Tw 0 -1.315 TD (Placebo-controlled trials suggested )Tj 0.0002 Tc -0.001 Tw 14.25 0 Td (a dose effect in the incidence of)Tj 0.0004 Tc -0.0016 Tw 12.71 0 Td [( som)8.2 (e)-0.8 ( adverse events \(headache, )]TJ -0.0003 Tw -26.96 -1.15 Td (flushing, dyspepsia, nausea, rhinitis\) over the )Tj 0.0001 Tc 0.0004 Tw 18.37 0 Td [(5 mg, 10 m)7.9 (g, and 20 m)7.9 (g doses of LEVITRA. The )]TJ 0.0008 Tc -0.0018 Tw -18.37 -1.15 Td [(f)3.8 (o)0.8 (llowing se)4.6 (ction identif)3.8 (i)-1.4 (es add)5.8 (ition)5.8 (a)4.6 (l, less f)3.8 (r)-1.2 (equ)5.8 (e)]TJ 0.001 Tc 19.99 0 Td [(nt events \(<)5 (2%\) repo)6 (rte)4.8 (d)1 ( during th)6 (e clin)6 (ical )]TJ 0.0006 Tc -0.002 Tw -19.99 -1.15 Td [(developm)8.4 (ent of LEVITRA.
Excluded from)8.4 ( this list ar)]TJ -0.0027 Tw 21.44 0 Td [(e those events that are infrequ)5.6 (e)4.4 (nt and m)8.4 (i)-1.6 (nor, )]TJ 0.0003 Tc -0.0009 Tw -21.44 -1.145 Td [(those events that m)8.1 (a)-0.9 (y be commonly observed in the )]TJ 0.0001 Tc -0.0013 Tw (absence of drug therapy, a)Tj 0.0003 Tc -0.0015 Tw 31.49 0 Td (nd those events that are )Tj -0.0001 Tc 0.0001 Tw -31.49 -1.155 Td (not reasonably associated with the drug. )Tj 0 Tc 0.0037 Tw 1.5 -1.315 Td (BODY AS A WHOLE: anaphylactic)Tj 0.0008 Tc -0.0015 Tw 14.775 0 Td [( reaction \(in)5.8 (cluding lary)5.8 (ngeal edem)8.6 (a\), asthen)5.8 (ia, f)8.8 (ace edem)8.6 (a, )]TJ 0.0009 Tc 0 Tw -14.775 -2.3 Td (pain )Tj 0.0004 Tc -0.0004 Tw 0 -2.805 TD [(AUDITOR)-2.6 (Y)2.6 (: tinnitus )]TJ -0.0003 Tc 0.0003 Tw 0 -1.31 TD [(CARDIOVASCULAR:)-7.5 ( angina pectoris, ches)]TJ 0.0003 Tc -0.0003 Tw 18.11 0 Td [(t pain, hypertension, hypotension, m)8.1 (yocardial )]TJ 0.0005 Tc -0.0005 Tw -18.11 -1.155 Td [(ischem)8.3 (ia, myocardial inf)8.5 (a)-0.7 (rction, palpitation, )]TJ -0.0001 Tc 0.0001 Tw 17.97 0 Td (postural hypotension, s)Tj 0 Tc 0 Tw 9.245 0 Td (yncope, tachycardia )Tj 0.0002 Tc -0.0002 Tw -27.215 -1.31 Td [(DIGESTIVE: abdom)8 (inal pain, abnorm)8 (al liver f)]TJ -0.0027 Tw 18.88 0 Td [(unction tests, diarrhea, dry )-7.5 (m)8 (outh, dysphagia, )]TJ 0.0005 Tc -0.003 Tw -18.88 -1.155 Td [(esophagitis, gastritis, gas)4.7 (t)-1.7 (roesophag)5.5 (e)]TJ 0.0006 Tc -0.0006 Tw 14.83 0 Td [(al reflux, G)7.8 (G)2.8 (TP increas)4.8 (ed, vom)8.4 (iting )]TJ 0.0004 Tc -0.0004 Tw -14.83 -1.32 Td (MUSCULOSKELETAL: arthra)Tj 0.0005 Tc -0.0025 Tw 12.805 0 Td (lgia, back pain, myalgia, neck pain )Tj 0.0001 Tc -0.0017 Tw -12.805 -1.315 Td [(NERVOUS:)-7.1 ( hypertonia, hypesthesia, insom)7.9 (nia)]TJ 0.0002 Tc 18.855 0 Td [(, paresthesia, som)8 (nolence, vertigo )]TJ 0.0004 Tc -0.0004 Tw -18.855 -1.315 Td (RESPIRATORY: dyspnea, ep)Tj -0.0003 Tc 0.0003 Tw 12.09 0 Td (istaxis, pharyngitis )Tj 0 Tc 0.0016 Tw -12.09 -1.32 Td (SKIN AND APPENDAGES: photosensitivity)Tj 0.0002 Tc -0.0014 Tw 18.42 0 Td ( reaction, pruritus, rash, sweating )Tj ET q 1 0 0 1 -8.195038 -34.037292 cm /CS0 CS 0.004 0.004 0.004 SCN 0.75 w 1 j 1 J q 1 0 0 1 61.2 652.08 cm 0 0 m 432 0 l 0.48 -22.68 m 432.48 -22.68 l 0.48 -60.3 m 432.48 -60.3 l 0 -203.7 m 432 -203.7 l S Q Q /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 201 0 obj <>>>/Resources 234 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 202 0 obj <>>>/Resources 236 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 236 0 obj <> endobj 237 0 obj <> endobj 235 0 obj <>stream �5H�8CTzd#E���[��w���ᮆ�)ȼ�7�)��ࢠ1�97���8�������{�s ��~�N�4T$�C#A�}�A�_��r�y���XXm�d�=��jc����}�jˇX���(��?
Proportion of vardenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm concentrationdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm countdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Proportion of sildenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo and vardenafil after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Washington, DC - The FDA gave approval yesterday to vardenafil (Levitra®, Bayer and Glaxo Smith Kline), an oral erectile-dysfunction drug that works through the same mechanism as sildenafil (Viagra®, Pfizer). Like sildenafil, vardenafil can seriously affect blood pressure and should not be taken by those on alpha blockers or nitrates. The recommended dose is 10 mg taken one hour before sexual activity, with 20-, 5.0-, and 2.5-mg doses available. Vardenafil is a phosphodiesterase inhibitor and, like sildenafil, is strongly contraindicated if patients are taking nitrates (nitroglycerin tablets or patches) or alpha blockers, due to the possibility of a steep drop in blood pressure.